Rocket One Inc. Common Stock (NASDAQ:RKTO) Stock Short Interest Drops 52.8%

Rocket One Inc. Common Stock (NASDAQ:RKTO) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 992,927 shares, a decrease of 52.8% from the September 15th total of 2,105,431 shares. Currently, 4.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 496,261 shares, the short-interest ratio is presently 2.0 days.

Rocket One Inc. Common Stock Stock Down 4.2%

RKTO traded down $0.02 during trading on Friday, reaching $0.51. The company had a trading volume of 107,705 shares, compared to its average volume of 4,187,291. Rocket One Inc. Common Stock has a 52 week low of $0.49 and a 52 week high of $2.45. The business has a 50 day simple moving average of $0.72 and a 200-day simple moving average of $0.83. The stock has a market cap of $11.48 million, a P/E ratio of -0.63 and a beta of 0.90.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.19) EPS for the quarter.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a report on Sunday, August 16th. Weiss Ratings downgraded Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Rocket One Inc. Common Stock has an average rating of “Hold” and a consensus price target of $5.00.

Institutional Investors Weigh In On Rocket One Inc. Common Stock

A hedge fund recently raised its position in Rocket One Inc. Common Stock stock. Lido Advisors LLC increased its holdings in Rocket One Inc. Common Stock (NASDAQ:RKTO) by 100.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,000 shares of the company’s stock after acquiring an additional 19,500 shares during the quarter. Lido Advisors LLC owned approximately 0.20% of Rocket One Inc. Common Stock worth $33,000 as of its most recent SEC filing. 7.08% of the stock is owned by hedge funds and other institutional investors.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation, which is in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases; and HT-002, a novel peptide for treating COVID-19.